PATENT CLAIM ANALYSIS

Application Number: 15759161
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "493000"]

Abstract:
A method for treating leukemia is disclosed. The method comprises administering to a subject with leukemia an effective amount of a pharmaceutical composition comprising a naked iron oxide nanoparticle, wherein the composition is not loaded with an active agent. Also disclosed is a method for treating cancer. The method comprises administering an effective amount of a pharmaceutical composition comprising a metal oxide nanoparticle comprising a polymeric coating over a metal oxide core, wherein the nanoparticle is loaded with a reactive oxygen species (ROS)-inducing agent.

Claim (Index 4):
The method of  claim 3 , wherein the reactive oxygen species (ROS) generating agent selected from the group consisting of A-type proanthocyanidins (A-PACs), erastin, bortezomib, parthenolide, elesclomol, and a combination of any two or more thereof.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 90.0
- Lexical Diversity: 1.97872
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12416993', '12169532', '14130909', '15142912', '14811490']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7745617849603041
- 35 USC 102 Novelty (BERT): 0.5137229449126312
- Combined Prediction Score: 0.7484779009555369
- Mean Citation Score: 243.629548
- Max Citation Score: 274.785
- Similarity Product: 168.55945264309645

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test